Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
4,401
+832
+23% +$285K 0.1% 200
2026
Q1
$1.26M Buy
3,569
+4
+0.1% +$1.43K 0.1% 184
2025
Q4
$1.17M Sell
3,565
-412
-10% -$131K 0.09% 192
2025
Q3
$1.12M Buy
3,977
+540
+16% +$157K 0.09% 189
2025
Q2
$960K Sell
3,437
-764
-18% -$216K 0.09% 199
2025
Q1
$1.31M Buy
4,201
+763
+22% +$225K 0.14% 155
2024
Q4
$896K Buy
3,438
+872
+34% +$259K 0.09% 192
2024
Q3
$827K Hold
2,566
0.1% 183
2024
Q2
$802K Sell
2,566
-139
-5% -$40.8K 0.12% 171
2024
Q1
$769K Buy
2,705
+964
+55% +$282K 0.12% 184
2023
Q4
$501K Sell
1,741
-219
-11% -$59.7K 0.1% 215
2023
Q3
$527K Buy
1,960
+179
+10% +$44.7K 0.14% 166
2023
Q2
$395K Sell
1,781
-65
-4% -$15.1K 0.11% 206
2023
Q1
$446K Buy
1,846
+1,014
+122% +$249K 0.13% 176
2022
Q4
$218K Buy
+832
New +$223K 0.08% 242
2021
Q3
Sell
-868
Closed -$212K 260
2021
Q2
$212K Buy
+868
New +$214K 0.1% 204

Other funds holding AMGN

MONECO Advisors's AMGN Position: Q2 2026 in Review

MONECO Advisors increased its Amgen (AMGN) stake by 23% in Q2 2026, buying an estimated $285K and bringing the position to 4,401 shares worth $1.59M. The position accounts for 0.1% of the portfolio, ranked #200.

MONECO Advisors first reported a position in AMGN in Q2 2021 and has held it in 16 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • MONECO Advisors held 4,401 shares of Amgen worth $1.59M as of Q2 2026.
  • MONECO Advisors bought 832 Amgen shares in Q2 2026, an estimated $285K.
  • Amgen made up 0.1% of MONECO Advisors's portfolio in Q2 2026, its #200 holding.
  • MONECO Advisors first reported a position in Amgen in Q2 2021 and has held it in 16 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MONECO Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.